2016
DOI: 10.1002/psb.1445
|View full text |Cite
|
Sign up to set email alerts
|

Vortioxetine for the treatment of major depression in adults

Abstract: Vortioxetine (Brintellix) is a new antidepressant recently recommended by NICE as third‐line therapy for the treatment of major depressive episodes in adults. This article describes the drug's properties, clinical trial evidence for its efficacy and its adverse effects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 2 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?